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Microglial priming and enhanced reactivity to secondary insults cause substantial neuronal
damage and are hallmarks of brain aging, traumatic brain injury and neurodegenerative dis-
eases. It is, thus, of particular interest to identify mechanisms involved in microglial priming.
Here, we demonstrate that priming of microglia with interferon-γ (IFN γ) substantially
enhanced production of reactive oxygen species (ROS) following stimulation of microglia with
ATP. Priming of microglial ROS production was substantially reduced by inhibition of p38
MAPK activity with SB203580, by increases in intracellular glutathione levels with N-Acetyl-L-
cysteine, by blockade of NADPHoxidase subunit NOX2 activity with gp91ds-tat or by inhibition
of nitric oxide production with L-NAME. Together, our data indicate that priming of microglial
ROS production involves reduction of intracellular glutathione levels, upregulation of NADPH
oxidase subunit NOX2 and increases in nitric oxide production, and suggest that these simul-
taneously occurring processes result in enhanced production of neurotoxic peroxynitrite. Fur-
thermore, IFNγ-induced priming of microglial ROS production was reduced upon blockade of
Kir2.1 inward rectifier K+ channels with ML133. Inhibitory effects of ML133 onmicroglial prim-
ing were mediated via regulation of intracellular glutathione levels and nitric oxide production.
These data suggest that microglial Kir2.1 channels may represent novel therapeutic targets to
inhibit excessive ROS production by primed microglia in brain pathology.
Introduction
Production of large amounts of reactive oxygen species (ROS) and subsequent oxidative stress
play a pivotal role in neurological diseases, while activated microglial cells are the major source
of ROS production in brain pathology [1, 2]. Although ROS can have beneficial roles via regu-
lation of cellular signaling mechanisms [3], excessive ROS production by microglia has detri-
mental effects on surrounding neurons via oxidative damage of neuronal lipids, proteins and
DNA. Furthermore, intracellularly produced ROS can contribute to microglial neurotoxicity
by enhancing the production of proinflammatory substances [2, 4, 5].
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Activation of microglia with an appropriate stimulus, such as ATP [6], induces NADPH
oxidase activity leading to the production of a certain amount of ROS. Pre-exposure of micro-
glia to various agents, which do not cause ROS production themselves, can lead to significant
enhancement of ROS production upon subsequent stimulation, e.g., with ATP. This process is
known as "priming" [7]. Agents capable of priming microglial ROS production include amy-
loid-β [8–10], cytokines, such as interferon-γ (IFNγ) [11, 12] and tumor necrosis factor-α [11,
12], HIV-1 Nef protein [13], paraquat [14] and others. Priming agents, which do not induce,
but potentiate ROS production have first been identified and subsequently thoroughly investi-
gated in neutrophils [7, 15]. The number of substances causing priming of ROS production by
neutrophils [7] is larger than that of priming agents found to date in microglia. However, it can
be expected that the list of microglial priming agents will further expand due to the growing
interest in microglial priming and activation.
Microglial priming represents one of the mechanisms leading to excessive ROS production
and subsequent neuronal damage in brain pathology [1]. It is now well recognized that brain
aging, traumatic brain injury and neurodegenerative diseases lead to the formation of primed
microglia [1, 16, 17], while the proinflammatory cytokine IFNγ has been identified as a micro-
glial priming factor. Under pathological conditions, infiltration of IFNγ-producing T cells in
the brain is enhanced due to brain damage or aging-associated increased permeability of the
blood brain barrier. Consequently, enhanced IFNγ concentrations have been found in the aged
brain [18], following traumatic brain injury [19] and at early stages of neurodegenerative dis-
eases, including Alzheimer’s disease [20], Parkinson’s disease [21] and vascular dementia [22].
In this study, we investigated IFNγ-induced priming of microglial ROS production. We
identified mechanisms underlying this priming process and suggest that microglial Kir2.1
channels represent potential therapeutic targets to reduce excessive ROS production by primed
microglia in brain pathology.
Materials and Methods
Cell Culture
All experiments were performed on BV-2 microglial cells (kindly provided by Dr. E. Blasi,
Perugia, Italy), which resemble primary cultured microglia and microglia in brain tissue in
their ion channel expression pattern as well as in their capability to produce ROS [10, 23, 24].
BV-2 microglial cells were cultured in FCS-containing DMEM culture medium as described
previously [10]. For ROS, glutathione and nitric oxide imaging experiments, cells were plated
in black 24-well plates with glass bottom (Greiner Bio One, Stonehouse, UK) at a density of
5x104 cells/well. 30 min after plating, cells were treated without or with the following inhibitors
as indicated: 20 μMML133 hydrochloride (ML133; R&D systems, Abingdon, UK); 100 nM
5-iodo-resiniferatoxin (I-RTX; Alomone Lab, Jerusalem, Israel); 1 μMmargatoxin (MTX; Pep-
taNova, Sandhausen, Germany); 20 μM 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-
(4-pyridyl)-1H-imidazole (SB203580); 20 μM 2'-Amino-3'methoxyflavone (PD98059); 5 μM
N-(p-Amylcinnamoyl)anthranilic acid (ACA) (all three fromMerckmillipore, Darmstadt, Ger-
many); 1 μM 1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34); 50 μMN-[(1R)-
1,2,3,4-Tetrahydro-1-naphthalenyl]-1H-Benzimidazol-2-amine hydrochloride (NS8593); 1
mMN-Acetyl-L-cysteine (NAC) (all three from Sigma-Aldrich, Dorset, UK). 30 min after
drug pretreatment, in some cases 10 ng/ml or 50 ng/ml interferon-γ (IFNγ; R&D systems,
Abingdon, UK) was added to the culture medium as indicated. Thereafter, cells were incubated
in a cell culture incubator at 37°C for 24 h, i.e., cells were primed as indicated. In our experi-
ments, IFNγ was used at concentrations similar to those found to initiate priming of NADPH
oxidase activity in human and mouse microglia [11, 12].
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After priming, the culture medium was removed and cells were treated with DMEM con-
taining the appropriate fluorescent dye with or without 2 mMNa2ATP (Sigma-Aldrich, Dor-
set, UK) at 37°C for 1 h to stimulate microglial ROS production. 2 mM ATP was used in these
experiments, because this ATP concentration is in the physiological range [25, 26]. It has been
demonstrated previously that ATP stimulates NADPH oxidase-mediated microglial ROS pro-
duction via activation of P2X7 receptors [6], which have an activation threshold of 1 mM ATP.
Our preliminary experiments revealed that 2 mM ATP causes significant ROS production by
microglia, while this concentration is still below the ATP concentration leading to maximum
ROS production (data not shown). These are optimal conditions for studying priming of
microglial ROS production.
ROS Imaging
To study microglial ROS production, cells were loaded with 10 μMCM-H2DCFDA (Molecular
Probes, Paisley, UK) in presence or absence of ATP. In some cases, 10 μM gp91ds-tat (Ana-
Spec, Fremont, USA) or 200 μMNω-Nitro-L-arginine methyl ester hydrochloride (L-NAME;
Sigma-Aldrich, Dorset, UK) were added to the medium as indicated. These inhibitors were
additionally present in the IFNγ priming medium for a certain time (L-NAME for 30 min;
gp91ds-tat for 2 h) prior to medium exchange. Thereafter, cells were washed with extracellular
medium E1 containing: 130 mMNaCl, 5 mM KCl, 2 mM CaCl2, 1 mMMgCl2, 100 μMGdCl3,
10 mMHEPES, 10 mMD-glucose (pH = 7.4). Fluorescence intensity of cells was captured
using an imaging system consisting of an inverted microscope IX50 equipped with a 40X water
immersion objective UApo/340 (Olympus, Hamburg, Germany), a Hamamatsu Orca 03G
camera, a monochromator Polychrome V (both from Till Photonics, Munich, Germany), a
dichroic mirror of 505 nm wavelength, and a barrier filter of 530±20 nm wavelength (both
from Olympus, Hamburg, Germany). Cells were excited at 480 nm and images were captured
for at least four different visual fields from at least two independent experiments for each con-
dition using the Live Acquisition software (Till Photonics, Munich, Germany). Background
corrected fluorescence intensities of individual cells were determined using ImageJ v1.50 (NIH,
Bethesda, USA), while “n” represents the number of cells analyzed.
Nitric Oxide Imaging
After priming, cells were treated with DMEM containing 10 μM 4-Amino-5-Methylamino-
2',7'-Difluorofluorescein Diacetate (DAF-FM; ThermoFisherScientific, Paisley, UK) with or
without ATP as indicated. In some cases, 200 μM L-NAME was added to the stimulation
medium and was additionally present in the IFNγ priming medium for 30 min prior to
medium exchange. Thereafter, cells were washed with medium E1. Fluorescence intensity of
cells was captured using an imaging system and filter sets as described above for DCFDA-
based ROS imaging. Images were captured for at least four different visual fields from at least
two independent experiments for each condition using the Live Acquisition software (Till Pho-
tonics, Munich, Germany). Background corrected fluorescence intensities of individual cells
were determined using ImageJ v1.50 (NIH, Bethesda, USA), while “n” represents the number
of cells analyzed.
Glutathione Imaging
To determine glutathione levels, cells were primed as indicated. Thereafter, the medium was
removed and cells were exposed to DMEM containing 30 μMmonochlorobimane (mBCl;
Molecular Probes, Paisley, UK) for 30 min in the cell culture incubator. Following this incuba-
tion, the medium was removed and replaced with medium E1. Fluorescence intensity of mBCl-
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loaded cells was captured using the same imaging system described above, but using a dicroic
mirror of 400 nm and a 420 nm long pass emission filter. Cells were excited at 380 nm using
the monochromator. Images were captured for at least four different visual fields from at least
two independent experiments for each condition using the Live Acquisition software (Till Pho-
tonics, Munich, Germany). Background corrected fluorescence intensities of individual cells
were determined using ImageJ v1.50 (NIH, Bethesda, USA), while “n” represents the number
of cells analyzed. To check the specificity of mBCL for glutathione over other thiols, 500 μM
ethacrynic acid (Santa Cruz Biotechnology, Dallas, USA), an inhibitor of glutathione S-trans-
ferase, was added 10 min prior to exposure of cells to mBCl in a paired well, and mBCl fluores-
cence intensities were corrected for these values.
Cell Viability
In all imaging experiments, data were collected exclusively from intact cells. Cell viability was
assessed via dye loading properties of the cells. Damaged cells were defined as cells, which had
lost fluorescent dyes due to loss of membrane integrity. In all experimental conditions, dam-
aged cells were rarely found (<1% of all cells) and were excluded from further analyses.
Quantitative RT-PCR
For quantitative RT-PCR experiments, cells were plated in 6-well plates at a density of 0.5x106
cells/well and were either kept untreated or treated with 50 ng/ml IFNγ in presence or absence of
inhibitors for 24 h prior to RNA isolation. Quantitative RT-PCR experiments were performed in
three different cell cultures as described previously [27]. In brief, RNA was purified with E.Z.N.A
Total RNA kit (Omega Bio-tek, Norcross, USA). RNA was DNAse I treated in-column during
the purification process and 500 ng RNA were reverse transcribed using random hexamers and
Maxima reverse transcriptase according to manufacturer’s instructions (Fisher Scientific, Hamp-
ton, USA). Quantitative PCR was conducted on a C1000 Thermal Cycler (Biorad, Hercules,
USA) with 30 ng of reverse transcribed RNA and DyNAmo Flash SYBR Green qPCRmix
(Thermo Scientific, Walham, USA) using the following mouse specific primers: NOX1 (Forward,
50-AATGCCCAGGATCGAGGT-30; Reverse, 50-GATGGAAGCAAAGGGAGTGA-30), NOX2
(Forward, 50-CCCTTTGGTACAGCCAGTGAAGAT-30; Reverse, 50-CAATCCCGGCTCCCA
CTAACATCA-30), NOX4 (Forward, 50-GGATCACAGAAGGTCCCTAGCAG-30; Reverse, 50-
GCGGCTACATGCACACCTGAGAA-30), L7 (Forward, 5’-GAAGCTCATCTATGAGAA
GGC-3’; Reverse, 5’-AAGACGAAGGAGCTGCAGAAC-3’). Primers for the ribosomal protein
L7 RNA were used as a control.
Statistics
All data are presented as mean ± SEM. Statistical significance of differences between experi-
mental groups was evaluated using SPSS v22 (IBM, Armonk, USA). For data analysis of qPCR
experiments, Student’s t-test was used. In all other cases, one-way ANOVA with Dunnett’s T3
post hoc tests was used after testing for equal variances with Levene’s test. Data were consid-
ered to be statistically significant with p<0.05.
Results
IFNγ-Induced Priming of Microglial ROS Production
Fig 1 demonstrates brightfield images and DCFDA fluorescence images of microglial cells,
which were kept untreated or were treated with 2 mM ATP for 1 h following pretreatment with
IFNγ for 24 h. Analysis of DCFDA fluorescence intensities as a measure for microglial ROS
IFNγ-Induced Priming of Microglial ROS Production
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Fig 1. IFNγ-induced priming of ATP-stimulated ROS production by microglia. (A-C) Examples of cells
(upper images: brightfield images; lower images: DCFDA fluorescence images) kept unprimed (A) or primed
with 10 ng/ml IFNγ (B) or 50 ng/ml IFNγ (C) for 24 h and maintained subsequently with or without 2 mM ATP
for 1 h. Scale bars: 20 γm. (D) Mean DCFDA fluorescence intensities of cells maintained unprimed for 24 h
and then either kept unstimulated (n = 1134) or stimulated with 2 mM ATP (n = 1137) for 1 h, of cells primed
IFNγ-Induced Priming of Microglial ROS Production
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production revealed significant increases in microglial cells stimulated with ATP. Without
IFNγ priming, ROS production of ATP-stimulated cells was 6.5-fold higher than that of unsti-
mulated cells (p<0.001; Fig 1A, Fig 1D). Priming of microglial cells with IFNγ significantly
increased DCFDA staining intensities of cells, i.e., further enhanced microglial ROS production
following ATP stimulation. In comparison with cells kept unprimed, ATP-stimulated ROS
production was increased 3.2-fold (p<0.001; Fig 1B, Fig 1D) and 9.3-fold (p<0.001; Fig 1C, Fig
1D) in cells primed with 10 ng/ml IFNγ or 50 ng/ml IFNγ, respectively. In the absence of ATP
stimulation, IFNγ pretreatment did not induce substantial ROS production (Fig 1).
Additional experiments were performed in order to determine mechanisms underlying
IFNγ-induced priming of microglial ROS production. Microglia were primed with 50 ng/ml
IFNγ to achieve a good signal-to-noise ratio in these fluorescence imaging experiments. To
identify intracellular signaling pathways involved in IFNγ-induced priming of microglial ROS
production, effects of the p38 MAPK inhibitor SB203580 and of the p42/44 ERK1/2 inhibitor
PD98059 were investigated. Fig 2 shows ATP-stimulated ROS production in cells primed with
IFNγ in presence or absence of either 20 μM SB203580 or 20 μM PD98059. Inhibition of p38
MAPK activity almost completely inhibited the IFNγ-induced priming effect (p<0.001; Fig
2A), whereas inhibition of ERK1/2 activity did not significantly affect IFNγ-induced priming
of microglial ROS production (p = 1.0; Fig 2B).
Next, we investigated the role of K+ and TRP channels in priming of microglial ROS pro-
duction. In these experiments, microglial cells were primed with 50 ng/ml IFNγ in presence or
absence of ion channel inhibitors. Blockade of Kir2.1 inward rectifier K+ channels with 20 μM
ML133 inhibited IFNγ-induced priming of ATP-stimulated ROS production by 76.8%
for 24 h with 10 ng/ml IFNγ and then not stimulated (n = 216) or stimulated with 2 mM ATP (n = 264) for 1 h, or
cells primed for 24 h with 50 ng/ml IFNγ and subsequently kept unstimulated (n = 240) or stimulated with 2
mM ATP (n = 1089) for 1 h. Mean DCFDA fluorescence intensities of cells were normalized to the mean
fluorescence intensity determined for unprimed and unstimulated control cells. ***, p<0.001.
doi:10.1371/journal.pone.0162497.g001
Fig 2. Effects of inhibitors of p38 MAPK and p42/44 ERK1/2 kinase activity on IFNγ-induced priming of ATP-stimulated
ROS production by microglia. Cells were primed for 24 h with 50 ng/ml IFNγ in absence or presence of p38 MAPK inhibitor
20 μMSB203580 (A; n = 323 no priming, n = 247 IFNγ, n = 213 IFNγ+SB203580), or p42/44 ERK1/2 kinase inhibitor 20 μM
PD98059 (B; n = 323 no priming, n = 247 IFNγ, n = 228 IFNγ+PD98059). After individual priming, all cells were stimulated with 2
mM ATP for 1 h. Mean DCFDA fluorescence intensities of cells were normalized to the mean fluorescence intensities
determined for unprimed ATP-stimulated cells. ***, p<0.001; n.s., not significant.
doi:10.1371/journal.pone.0162497.g002
IFNγ-Induced Priming of Microglial ROS Production
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(p<0.001; Fig 3A). In contrast, blockade of Kv1.3 voltage-gated outward rectifier K+ channels
with 1 μMMTX (p = 1.0; Fig 3B) or inhibition of KCa3.1 IK-type Ca2+-activated K+ channels
with 1 μMTRAM-34 did not significantly alter the IFNγ-induced priming effect (p = 1.0; Fig
3C). Furthermore, none of the tested TRP channel inhibitors attenuated the priming effect of
IFNγ on microglial ROS production. No significant differences in ROS production were
observed between ATP-stimulated cells primed with 50 ng/ml IFNγ in absence or presence of
TRPV1 channel inhibitor I-RTX (100 nM; p = 1.0; Fig 3D) or TRPM2 channel inhibitor ACA
(5 μM; p = 0.998; Fig 3E). Intriguingly, inhibition of TRPM7 channels with 50 μMNS8593 fur-
ther enhanced the priming effect of IFNγ on microglial ROS production. In comparison with
cells primed with IFNγ alone, ROS production by ATP-stimulated microglial cells was
increased 4-fold (p<0.001) in cells primed with IFNγ in the presence of NS8593 (Fig 3F).
Control experiments revealed that SB203580 and ML133 selectively inhibited priming of
microglial ROS production without having direct inhibitory effects on ATP-stimulated ROS
production. 24 h-lasting pretreatment of cells with SB203580 or ML133 in the absence of IFNγ
did not inhibit microglial ATP-stimulated ROS production (p = 0.565, n = 214 for SB203580;
p = 1.0, n = 211 for ML133; data not shown).
In summary, these data suggest that IFNγ induces priming of microglial ATP-stimulated
ROS production, which involves activity of p38 MAPK and Kir2.1 inward rectifier K+ channels.
Further experiments aimed (i) to identify mechanisms causing priming of microglial ROS pro-
duction and (ii) to elucidate mechanisms by which inhibitors of p38 MAPK and Kir2.1 K+
channels modulate the IFNγ-induced priming effect.
IFNγ-Induced Changes in Microglial Glutathione Levels
IFNγ priming of microglia causes a reduction in the levels of intracellular glutathione (GSH),
which is one of the most abundant antioxidants in microglia [4]. Fig 4A demonstrates mBCl
fluorescence images as a measure of GSH levels in untreated microglia and in microglia treated
for 24 h with either 10 ng/ml IFNγ or 50 ng/ml IFNγ. Quantitative analyses of mBCl fluores-
cence intensities revealed that IFNγ reduced GSH levels in microglia in a concentration-depen-
dent manner. In comparison with untreated microglia, GSH levels were reduced by 53.9%
(p<0.001) or by 73.3% (p<0.001) following 24 h-lasting exposure of cells to 10 ng/ml IFNγ or
50 ng/ml IFNγ, respectively (Fig 4B).
Next, we aimed to clarify whether augmented ROS levels determined in ATP-stimulated
microglia following IFNγ priming were due to reduced GSH levels, i.e., due to reduced antioxi-
dant capability of the cells. Therefore, we increased intracellular glutathione levels and tested
whether this procedure affects IFNγ-induced priming of microglial ROS production. As shown
in Fig 4C, addition of NAC to IFNγ-containing priming medium almost completely reversed
effects of IFNγ on intracellular GSH levels. In cells primed simultaneously with IFNγ and 1
mMNAC for 24 h, GSH levels were increased by 87.3% (p<0.001) compared to those deter-
mined in IFNγ-primed microglia. Fig 4D demonstrates that elevation of intracellular GSH lev-
els prevented the IFNγ-mediated priming effect on ATP-stimulated ROS production. In
comparison with cells primed exclusively with IFNγ, ATP-stimulated ROS production was
reduced by 74.7% (p<0.001) in cells primed with IFNγ in the presence of 1 mM NAC.
Furthermore, we tested whether inhibitory effects of SB203580 and/or ML133 on priming
of microglial ROS production were due to modulation of intracellular GSH levels. As shown in
Fig 4, inhibition of p38 MAPK with SB203580 (Fig 4E) or blockade of Kir2.1 K+ channels with
ML133 (Fig 4F) partially reversed the IFNγ-induced reduction of microglial GSH levels. In
comparison with microglia primed with IFNγ alone, GSH levels of microglia primed with IFNγ
and SB203580 were 37.5% higher (p<0.001), while GSH levels of microglia primed with IFNγ
IFNγ-Induced Priming of Microglial ROS Production
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Fig 3. Effects of K+ and TRP channel inhibitors on IFNγ-induced priming of ATP-stimulated ROS production by
microglia. Prior to stimulation, microglia were primed for 24 h without or with 50 ng/ml IFNγ and K+ channel inhibitors 20 μM
ML133 (A; n = 323 no priming, n = 247 IFNγ, n = 259 IFNγ+ML133), 1 μMMTX (B; n = 199 no priming, n = 191 IFNγ, n = 223
IFNγ+MTX) and 1 μM TRAM-34 (C; n = 323 no priming, n = 247 IFNγ, n = 295 IFNγ+TRAM-34) or TRP channel inhibitors 100 nM
I-RTX (D; n = 282 no priming, n = 280 IFNγ, n = 300 IFNγ+I-RTX), 5 μMACA (E; n = 282 no priming, n = 280 IFNγ, n = 190 IFNγ
+ACA) and 50 μMNS8593 (F; n = 282 no priming, n = 280 IFNγ, n = 183 IFNγ+NS8593). Following priming, all cells were
stimulated with 2 mM ATP for 1 h. Mean DCFDA fluorescence intensities of cells were normalized to mean fluorescence
intensities determined for unprimed ATP-stimulated cells. ***, p<0.001; n.s., not significantly different.
doi:10.1371/journal.pone.0162497.g003
IFNγ-Induced Priming of Microglial ROS Production
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and ML133 were 42.2% higher (p<0.001) than those determined for cells primed with IFNγ in
the absence of either SB203580 or ML133. In the absence of IFNγ, GSH levels of microglia
Fig 4. IFNγ-induced changes in microglial GSH levels. (A) Examples of cells (upper lane: brightfield images; lower lane: mBCl
fluorescence images) kept unprimed or primed with 10 ng/ml IFNγ or 50 ng/ml IFNγ for 24 h. Scale bars: 20 μm. (B) Mean mBCl
fluorescence intensities of cells maintained unprimed (n = 423) or primed with 10 ng/ml IFNγ (n = 295) or 50 ng/ml IFNγ (n = 370) for 24
h. (C) Intracellular GSH levels, i.e., mean mBCl fluorescence intensities of cells maintained unprimed or primed for 24 h with 50 ng/ml
IFNγ in absence or presence of 1 mMNAC (n = 389 no priming, n = 421 IFNγ, n = 242 IFNγ+NAC). (D) Effects of 1 mM NAC on IFNγ-
induced priming of microglial ROS production. Cells were kept unprimed or were primed for 24 h with IFNγ in absence or presence of 1
mMNAC as indicated (n = 298 no priming, n = 291 IFNγ, n = 277 IFNγ+NAC). Following priming, all cells were stimulated with 2 mM
ATP for 1 h. Mean DCFDA fluorescence intensities of cells were normalized to mean fluorescence intensities determined for unprimed
ATP-stimulated cells. (E-F) Effects of kinase and K+ channel inhibitors on IFNγ-induced changes in microglial GSH levels. Cells were
primed for 24 h without or with 50 ng/ml IFNγ and 20 μMSB203580 (E; n = 272 no priming, n = 279 IFNγ, n = 252 IFNγ+SB203580) or
20 μMML133 (F; n = 289 no priming, n = 258 IFNγ, n = 259 IFNγ+ML133). ***, p<0.001.
doi:10.1371/journal.pone.0162497.g004
IFNγ-Induced Priming of Microglial ROS Production
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treated with SB203580 or ML133 for 24 h were not significantly affected (p = 0.283, n = 223 for
SB203580; p = 0.955, n = 189 for ML133; data not shown).
IFNγ-Induced Changes in Microglial NOX Subunit Expression
We next investigated which NADPH oxidase subunits were expressed and upregulated by
IFNγ in microglia, and tested whether IFNγ-induced changes in expression levels of NADPH
oxidase subunit(s) were affected by SB203580 and/or ML133. To date, three NOX subunits
have been identified in microglia, namely NOX1, NOX2 and NOX4 [2]. To determine IFNγ-
induced changes in microglial NOX1, NOX2 and NOX4 mRNA levels, we used RT-qPCR. In
comparison with cells kept untreated, microglia primed with 50 ng/ml IFNγ for 24 h resulted
in a significant increase in NOX2 mRNA levels (205-fold; p<0.05; Fig 5A). In contrast to the
expression of NOX2 mRNA, expression of NOX1 mRNA was very low and did not change sig-
nificantly (p = 0.170) following priming of cells with IFNγ (Fig 5A). In all three independent
experiments, expression of NOX4 mRNA was undetectable at each of the experimental condi-
tions tested.
To verify the priming effect of IFNγ on NOX2 expression, we additionally tested effects of
the specific NOX2 inhibitor gp91ds-tat (10 μM) on ATP-stimulated ROS production in IFNγ-
primed microglia. As demonstrated in Fig 5B, IFNγ-induced upregulation of ATP-stimulated
ROS production was abolished by gp91ds-tat (p<0.001), suggesting that enhanced ROS pro-
duction of IFNγ-primed microglia was mediated exclusively by the activity of NADPH oxidase
subunit NOX2.
To identify the role of p38 MAPK and Kir2.1 K+ channels in regulating NOX2 levels in
IFNγ-primed microglia, we additionally investigated effects of SB203580 and ML133 on micro-
glial NOX2 mRNA expression. As demonstrated in Fig 5C, NOX2 mRNA levels of IFNγ-
primed microglia were reduced by 82.7% (n = 3; p<0.05) upon inhibition of p38 MAPK with
SB203580. In contrast, K+ channel inhibition with ML133 (n = 3; p = 1.0) did not affect NOX2
mRNA levels in IFNγ-primed microglia (Fig 5C).
IFNγ-Induced Changes in Microglial NO Production
As demonstrated in Fig 6A and Fig 6B, ATP-stimulated NO production of microglial cells was
also enhanced following IFNγ priming. Stimulation of unprimed microglia with 2 mM ATP
for 1 h increased DAF-FM fluorescence intensities as a measure for NO production 2.3-fold
(p<0.001) compared to unstimulated cells. In microglia primed with 50 ng/ml IFNγ for 24 h,
ATP-stimulated NO production was 2.9-fold (p<0.001) higher than in unprimed ATP-stimu-
lated cells (Fig 6B). As demonstrated in Fig 6C, inhibition of NO production almost completely
inhibited ATP-stimulated ROS production of IFNγ-primed microglia. It was reduced by 89.2%
(p<0.001) in the presence of 200 μM L-NAME. These data suggest that ATP stimulation of
IFNγ-primed microglial cells mainly leads to the formation of peroxynitrite, a ROS detectable
by the fluorescent dye DCFDA.
NO production of IFNγ-primed microglia was significantly inhibited upon p38MAPK inhi-
bition or Kir2.1 K+ channel blockade. In cells primed with IFNγ and SB203580, ATP-stimu-
lated NO production was reduced by 41.7% (p<0.001) in comparison with cells primed with
IFNγ in the absence of SB203580 (Fig 6D). Furthermore, in comparison with cells primed with
IFNγ alone, ATP-stimulated NO production was significantly reduced by 51.4% (p<0.001) in
microglial cells primed with IFNγ in the presence of ML133 (Fig 6E). Control experiments
revealed that SB203580 and ML133 did not have a direct inhibitory effect on microglial NO
production. Statistically significant differences were not found in ATP-stimulated NO
IFNγ-Induced Priming of Microglial ROS Production
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Fig 5. IFNγ-induced changes in microglial expression levels of NOX subunits. (A) Expression of NOX1
and NOX2 in cells kept untreated or treated with 50 ng/ml IFNγ for 24 h. Using qPCR, NOX1 and NOX2
mRNA levels were determined and normalized to L7 mRNA levels. (B) Effects of NOX2 inhibitor gp91ds-tat
on microglial ATP-stimulated ROS production (n = 455 no priming, ATP stimulation; n = 338 IFNγ priming,
ATP stimulation; n = 363 IFNγ priming, ATP+gp91ds-tat stimulation). Prior to stimulation, microglia were
IFNγ-Induced Priming of Microglial ROS Production
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production between unprimed cells and cells primed for 24 h with SB203580 or ML133 in the
absence of IFNγ (p = 0.352, n = 225 for SB203580; p = 0.421, n = 172 for ML133; data not
shown).
Discussion
In this study, we elucidated mechanisms underlying priming of microglial ROS production.
We demonstrate that IFNγ-induced priming simultaneously stimulates three mechanisms,
namely (i) upregulation of NADPH oxidase subunit NOX2, (ii) upregulation of NO produc-
tion and (iii) reduction of intracellular GSH levels. All three mechanisms were found to be
dependent on p38 MAPK activity, whereas p42/p44 ERK was not involved. Furthermore, by
testing a variety of ion channel inhibitors, we identified Kir2.1 inward rectifier K+ channels as
crucial regulators of IFNγ-induced priming of microglial ROS production. Blockade of Kir2.1
channels inhibited effects of IFNγ on GSH levels and NO production. However, unlike p38
MAPK inhibition, Kir2.1 channel inhibition did not affect the upregulation of NOX2. These
data suggest that IFNγ-induced p38 MAPK and Kir2.1 inward rectifier K+ channel activity are
not directly linked.
In agreement with previous studies, treatment with ATP immediately stimulated microglial
ROS production [6], whereas the priming agent IFNγ did not induce substantial ROS or NO
production [11, 12]. Furthermore, our data demonstrate that IFNγ priming potentiates the
production of ROS and NO by ATP-stimulated microglia. In previous studies addressing
IFNγ-induced priming of ROS production, microglial cells were stimulated with the phorbol
ester PMA [11, 12], which exclusively activates the NADPH oxidase. To mimic pathophysio-
logical situations in vivo, we used ATP to induce microglial ROS production. For example,
traumatic brain injury and stroke are accompanied by substantial damage of neurons, which
contain ATP at millimolar concentrations [25, 26]. Our data suggest that ATP stimulation of
IFNγ-primed microglia activate both NADPH oxidase NOX2 and inducible nitric oxide
synthase (iNOS) causing simultaneous generation of superoxide anion and NO, which subse-
quently leads to the formation of peroxynitrite. Previous studies have demonstrated that perox-
ynitrite is more neurotoxic than superoxide or NO alone [4]. Reduction of glutathione levels
following priming of microglia with IFNγ further leads to increased peroxynitrite concentra-
tions, while addition of NAC to the external medium attenuated both IFNγ-induced reduction
in intracellular GSH levels and IFNγ-induced enhancement of ATP-stimulated ROS produc-
tion. Reduced glutathione levels have been found in primed microglia isolated from the aged
brain [28]. Furthermore, in brains of patients with neurodegenerative diseases, including Alz-
heimer’s disease and Parkinson’s disease, increased peroxynitrite production and reduced GSH
levels have been found [4, 29]. Thus, pharmacological tools inhibiting both enhanced peroxyni-
trite formation and reduction in GSH levels would provide a promising strategy to reduce
microglia-mediated oxidative stress in the brain of aged people and patients with neurodegen-
erative diseases.
Microglial ion channels have recently been identified as potential therapeutic targets in neu-
rological diseases [24, 30, 31], while K+, H+, transient receptor potential (TRP) and Cl- chan-
nels have been found to regulate microglial production of ROS [10, 32–37]. In this study, we
primed for 24 h without or with 50 ng/ml IFNγ. Following priming, cells were stimulated with 2 mM ATP in
absence or presence of 10 μM gp91ds-tat for 1 h. Mean DCFDA fluorescence intensities of cells were
normalized to mean fluorescence intensities determined for unprimed ATP-stimulated cells. (C) Relative
NOX2mRNA levels determined in microglia treated with 50 ng/ml IFN-γ for 24 h in absence or presence of
20 μMSB203580 or 20 μMML133 as indicated. ***, p<0.001; *, p<0.05; n.s., not significantly different.
doi:10.1371/journal.pone.0162497.g005
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Fig 6. IFNγ-induced changes in microglial NO production. (A) Examples of cells (upper images: brightfield images; lower
images: DAF-FM fluorescence images) kept unprimed or primed with 50 ng/ml IFNγ for 24 h and maintained subsequently with
or without 2 mM ATP for 1 h. Scale bars: 20 μm. (B) Mean DAF-FM fluorescence intensities of cells maintained unprimed for 24 h
and then either kept unstimulated (n = 288) or stimulated with 2 mM ATP (n = 240) for 1 h, or of cells primed for 24 h with 50 ng/ml
IFNγ and subsequently kept unstimulated (n = 304) or stimulated with 2 mM ATP (n = 224) for 1 h. (C) Inhibitory effects of 200 μM
L-NAME on ATP-stimulated ROS production by IFNγ-primed microglia (n = 371 no priming, ATP stimulation; n = 268 IFNγ
priming, ATP stimulation; n = 236 IFNγ priming, ATP+L-NAME stimulation). (D-E) Inhibitory effects of 20 μMSB203580 (D;
n = 156 no priming; n = 153 IFNγ priming; n = 185 IFNγ+SB203580 priming) and 20 μMML133 (E; n = 240 no priming; n = 224
IFNγ priming; n = 262 IFNγ+ML133 priming) on IFNγ-induced enhancement of microglial ATP-stimulated NO production. (C-E)
Prior to stimulation, microglia were primed for 24 h without or with 50 ng/ml IFNγ in absence or presence of inhibitors as
indicated. Following priming, cells were stimulated for 1 h with 2 mM ATP in absence or presence of inhibitors. Mean
fluorescence intensities of cells were normalized to mean fluorescence intensities determined for unprimed ATP-stimulated cells.
***, p<0.001.
doi:10.1371/journal.pone.0162497.g006
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elucidated a novel role of microglial Kir2.1 inward rectifier K+ channels, namely regulation of
microglial priming processes, which lead to enhanced microglial ROS production. We demon-
strate for the first time that Kir2.1 inward rectifier K+ channels are crucially involved in mecha-
nisms leading to reduced intracellular glutathione levels and upregulated NO production, two
processes contributing to IFNγ-induced priming of ROS production by ATP-stimulated micro-
glia. Kir2.1 inward rectifier K+ channels are expressed in rodent [38] and human microglia
[39]. Intriguingly, inward rectifier K+ channel expression is upregulated in microglia of aged
mice [40].
Kir2.1 inward rectifier K+ channels mainly regulate the resting membrane potential of
microglial cells, i.e., channel activity causes membrane hyperpolarization [24]. It is possible
that a negative membrane potential is a prerequisite to initiating or to maintaining microglial
priming processes. In microglia, IFNγcauses Ca2+ influx from the extracellular medium [41].
Increases in intracellular Ca2+ concentration stimulate activity of Ca2+/calmodulin-dependent
protein kinase II, which is involved in IFNγ-induced JAK/STAT1 pathway leading to increased
iNOS expression and subsequent NO production [42, 43]. Inhibition of microglial Kir2.1 chan-
nels causes a depolarization-mediated decrease in the driving force for Ca2+ influx [44], which
could be responsible for the observed attenuation of NO production. The precise mechanisms
by which Kir2.1 channel activity regulates NO production and intracellular glutathione levels
remain to be elucidated. It can be excluded that Kir2.1 channels regulate the activity of p38
MAPK, as NOX2 upregulation could only be inhibited by SB203580, but not by ML133.
In microglia, voltage-gated outward rectifier Kv1.3 channels have recently been found to
regulate NADPH oxidase priming induced by soluble amyloid-β [10]. In contrast, IFNγ-
induced priming of microglial ROS production does not require activity of Kv1.3 channels.
Even at a concentration 10-times higher than that used in the previous study by Schilling and
Eder [10], MTX did not affect IFNγ-induced priming of ATP-stimulated ROS production by
microglial cells (present study). These data suggest that K+ channel activity is required for opti-
mal priming of microglial ROS production, while the involvement of a specific K+ channel type
in microglial priming is stimulus-dependent.
In brain pathology, oxidative stress causing neuronal damage is mainly due to NADPH oxi-
dase-mediated excessive ROS production by activated microglia [1, 2]. Therefore, targeting
microglial NADPH oxidase NOX2 has been suggested as a promising strategy to prevent or
reduce oxidative stress-induced damage of brain tissue in neurological diseases, which are
accompanied by neuroinflammation [2, 45, 46]. However, complete inhibition of microglial
ROS production may not only affect neurotoxic effects, but also beneficial/neuroprotective
effects, of microglial cells. Blocking NOX2 could reduce antimicrobial effects leading to an
increased risk of infections and/or could inhibit important signaling pathways, which are regu-
lated by ROS and may contribute to microglial neuroprotective actions. In contrast, targeting
exclusively microglial priming processes would not abolish microglial ROS production, but
regulate the amount of ROS produced by activated microglia. It may provide a novel strategy
to selectively reduce microglia-mediated enhanced ROS production and subsequent oxidative
stress in brain pathology.
In summary, microglia priming leading to excessive ROS production upon secondary stim-
ulation represents a major risk factor for the development of neurodegenerative diseases. A bet-
ter understanding of mechanisms underlying priming of microglial ROS production may lead
to the development of strategies aiming at the reduction of microglia-induced neurotoxicity.
We suggest that inhibition of Kir2.1 channels provides a potential therapeutic strategy to
reduce microglial priming and subsequent enhanced oxidative stress in brain pathology.
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